Michael G Chen

US Patent:

7447942, Nov 4, 2008

Filed:

Jul 19, 2005

Appl. No.:

11/184224

Inventors:

Michael Chen - Kirkland WA, US
Mark S. Larsen - Redmond WA, US
James A. Stulz - Bellevue WA, US
Gregory Hogdal - Sammamish WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 11/00

US Classification:

714 38, 717129, 717124

Abstract:

A technique to implement software debugging capability using breakpoints includes creating breakpoints, storing them in a watchlist, and paging out a virtual address (VA) to physical address (PA) page entry in a translation look-aside buffer (TLB). When software under test is run at full speed, memory is accessed via the TLB VA to PA page translations. When a translation is missing, an exception is generated. Handling the exception includes determining if the page missing from the TLB matches a breakpoint address in the watchlist. The address and operation type are compared to the watchlist. If the operation matches the address and not the specified data, then the software under test is single stepped, the TLB page is removed and the software under test continues to execute. If the breakpoint and data type matches, then a debugger is notified and debugger action to service the breakpoint occurs.

US Patent:

20010037023, Nov 1, 2001

Filed:

Jun 4, 2001

Appl. No.:

09/873889

Inventors:

Michael Chen - Ann Arbor MI, US
Fu-Zon Chung - Ann Arbor MI, US
Helen Lee - Ann Arbor MI, US

International Classification:

C 07D 4 3/02

US Classification:

544/333000, 544/335000

Abstract:

The small nonpeptides of the instant invention are tachykinin antagonists. The compounds are highly selective and functional NKantagonists expected to be useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorders, inflammatory diseases, gastrointestinal disorders, vascular disorders, and neuropathological disorders.

US Patent:

20030073838, Apr 17, 2003

Filed:

Jun 21, 2002

Appl. No.:

10/177386

Inventors:

Michael Chen - Ann Arbor MI, US
Fu-Zon Chung - Ann Arbor MI, US
Helen Lee - Ann Arbor MI, US

International Classification:

C 07D 4 3/14

US Classification:

544/335000

Abstract:

The small nonpeptides of the instant invention are tachykinin antagonists. The compounds are highly selective and functional NKantagonists expected to be useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorders, inflammatory diseases, gastrointestinal disorders, vascular disorders, and neuropathological disorders.

US Patent:

20040039208, Feb 26, 2004

Filed:

Feb 7, 2003

Appl. No.:

10/344294

Inventors:

Michael Chen - Ann Arbor MI, US
Edward Davis - Zeeland MI, US
Javier Magano - Ypsilanti MI, US
Thomas Nanninga - Holland MI, US
Derick Winkle - Zeeland MI, US

International Classification:

C07D213/46
C07C255/50
C07C211/54

US Classification:

546/328000, 548/577000, 558/408000, 564/433000, 564/434000

Abstract:

The present invention relates to a process for the preparation of N-arylanthranilic acids, and a process for the preparation of N-aryl anthranilic esters, amides, and hydroxamic esters.

US Patent:

20100077385, Mar 25, 2010

Filed:

Sep 23, 2008

Appl. No.:

12/236174

Inventors:

Javier Nisim Flores Assad - Bothell WA, US
Michael Hung-Hsiang Chen - Bellevue WA, US
John Robert Eldridge - Bellevue WA, US
Gregory Hogdal - Sammamish WA, US

Assignee:

MICROSOFT CORPORATION - Redmond WA

International Classification:

G06F 9/44

US Classification:

717129

Abstract:

Filtering exceptions on a target computing device to selectively interrupt a host computing device based on rules. The rules represent user-defined scenarios, and each rule includes one or more criteria and a break decision. Upon detecting an exception on the target computing device, the target computing device evaluates the rules based on the criteria and information about the exception without notifying the host computing device. For example, a score is calculated for each rule, and the rule with the highest score is selected. The break decision associated with the selected rule is applied. For example, the break decision indicates that the exception is of interest and the host computing device should be notified, or that the exception does not match a scenario of interest and execution should continue without a break.

US Patent:

20230040415, Feb 9, 2023

Filed:

Sep 14, 2022

Appl. No.:

17/932260

Inventors:

- Boston MA, US
Michael C. Chen - Norwood MA, US
LuAnn Sabounjian - Holliston MA, US

International Classification:

A61K 31/4418
A61K 9/00
A61P 7/10
A61P 1/16

Abstract:

Disclosed herein are methods of treating lymphedema that include administering a clinically effective amount of deupirfenidone.

US Patent:

20210205283, Jul 8, 2021

Filed:

Jan 7, 2021

Appl. No.:

17/144018

Inventors:

- Boston MA, US
Michael C. Chen - Norwood MA, US
LuAnn Sabounjian - Holliston MA, US

Assignee:

PureTech LYT 100, Inc. - Boston MA

International Classification:

A61K 31/4412
A61P 11/00
A61P 29/00

Abstract:

Disclosed herein are deuterium-enriched N-Aryl pyridinone compounds, optionally in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising the same, methods of preparation thereof, and methods of use thereof. Such compounds and compositions are useful, for example, in treating diseases, disorders, or conditions such as edema.

US Patent:

20200368113, Nov 26, 2020

Filed:

Jul 7, 2020

Appl. No.:

16/922406

Inventors:

Changhai CHEN - Bloomfield Hills MI, US
Daniel CHEN - Bloomfield Hills MI, US
Michael CHEN - Bloomfield Hills MI, US

International Classification:

A61J 7/04
B65B 5/10
B65B 1/32
B65B 1/46
G16H 20/13
B65B 57/14

Abstract:

A medication dispensing system is provided and includes a medicine transfer device (MTD) and a controller. The MTD transfers medicine between first and second containers. The first container initially stores medicine. The controller: determines a first predetermined amount of medicine to be dispensed from the medicine dispensing system; causes the MTD to discharge a second predetermined amount of the medicine from the first container onto the MTD, and transfer a third predetermined amount of the medicine from the MTD to the second container; subsequent to the transfer of the third predetermined amount, determine whether the second container has greater than or equal to the first predetermined amount; and if the second container has less than the first predetermined amount, cause the MTD to transfer a portion of the medicine on the MTD into the second container or discharge a portion of the medicine in the first container onto the MTD.